Fact CheckerSign in

NCT07536542Recruiting

Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease

Effects of Dual-Task Training on Upper Extremity Function and Muscle Thickness in Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 2 Jun 2026

Brief summary (registry, in English)

The goal of this clinical trial is to investigate the effects of dual-task training on upper extremity function and muscle thickness in individuals with Parkinson's disease. The main questions it aims to answer are: Does dual-task training improve upper extremity function in individuals with Parkinson's disease? Does dual-task training lead to changes in upper extremity muscle thickness measured by ultrasonography? Researchers will compare a dual-task training group with a control group receiving routine care to determine whether 8 weeks of dual-task training results in greater improvements in upper extremity outco Participants will: complete baseline and post-intervention assessments of upper extremity function, muscle thickness, grip strength, and pinch strength be assigned to either a control group or a dual-task training group receive dual-task training 3 days per week for 8 weeks if assigned to the intervention group

Status (registry)
Recruiting
Study type
Interventional
Enrollment
38 (estimated)
First submitted
11 Apr 2026
Start date
24 Apr 2026
Primary completion date
24 Jul 2026
Lead sponsor
Ankara University
NCT number
NCT07536542

What you commit to

  • Study type: Interventional
  • Planned participants: 38
  • From 24 Apr 2026 to the primary completion date, 24 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Surgery, trauma, or immobilization involving the upper extremity within the last 6 months

Other illness

  • Advanced orthopedic condition affecting the upper extremity
  • Wound or dermatological condition preventing upper extremity ultrasonographic evaluation

Other

  • Atypical or secondary parkinsonism
  • Severe visual or hearing loss
  • Severe depression, psychosis, or communication difficulty
  • Any additional health problem preventing regular participation in the study

Who the study is looking for

  • Diagnosis of idiopathic Parkinson's disease confirmed by a neurologist
  • Modified Hoehn and Yahr stage 2 to 3
  • No medication or dosage change within the last 6 months
  • Cognitive capacity sufficient to understand and follow instructions, defined as Montreal Cognitive Assessment score ≥21
  • Voluntary participation with written informed consent

Age in the registry: 40 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hacettepe University
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.